Methodological Standards in Studies Evaluating the Dexamethasone Suppression Test

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. APA, Washington, D.C. 1980
   Google Scholar
• Amsterdam J. D., Winokur A., Caroff S. N., et al. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. American Journal of Psychiatry 1982; 139: 287–91
   PubMed Web of Science ®Google Scholar
• Berger M., Doerr P., Lund R., et al. Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?. Biological Psychiatry 1982; 17: 1217–39
   PubMed Web of Science ®Google Scholar
• Brown W. A., Johnston R., Mayfield D. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms and response to treatment. American Journal of Psychiatry 1979; 136: 543–7
   PubMedGoogle Scholar
• Brown W. A., Shuey I. Response to dexamethasone and subtype of depression. Archives of General Psychiatry 1980; 37: 747–51
   PubMed Web of Science ®Google Scholar
• Carroll B. J. Dexamethasone suppression test in depression (letter). Lancet 1980; 2: 1249
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Curtis G. C. Neuroendocrine identification of depressed patients. Australian and New Zealand Journal of Psychiatry 1976; 10: 13–20
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Curtis G. C., Mendels J. Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients. Archives of General Psychiatry 1976; 33: 1051–8
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Feinberg M., Greden J. F., et al. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. Journal of Affective Disorders 1980; 2: 177–94
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Feinberg M., Greden J. F., et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Archives of General Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Charles G., Vandewalle J., Meunier J. C., et al. Plasma urinary cortisol levels after dexamethasone in affective disorders. Journal of Affective Disorders 1981; 3: 397–406
   PubMed Web of Science ®Google Scholar
• Department Of Clinical Epidemiology And Biostatistics, McMASTER University Health Sciences Centre. How to read clinical journals: II. To learn about a diagnostic test. Canadian Medical Association Journal 1981; 124: 703–10
   PubMed Web of Science ®Google Scholar
• Dewan M. J., Pandurangi A. K., Boucher M. L., et al. Abnormal dexamethasone suppression test results in chronic schizophrenic patients. American Journal of Psychiatry 1982; 139: 1501–3
   PubMed Web of Science ®Google Scholar
• Feighner J. P., Robins E., Guze S. B., et al. Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 1972; 26: 57–63
   PubMed Web of Science ®Google Scholar
• Insel T. R., Kalin N. H., Guttmacher L. B., et al. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Research 1982; 6: 153–60
   PubMed Web of Science ®Google Scholar
• Liddle G. W. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology 1960; 20: 1539–60
   PubMed Web of Science ®Google Scholar
• Meltzer H. Y., Fang V. S., Tircou B. J., et al. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients. American Journal of Psychiatry 1982; 139: 763–68
   PubMed Web of Science ®Google Scholar
• Mendlewicz J., Charles G., Franckson J. M. The dexamethasone suppression test in affective disorder; relationship to clinical and genetic subgroups. British Journal of Psychiatry 1982; 141: 464–70
   PubMed Web of Science ®Google Scholar
• Nuller J. L., Ostroumova M. N. Resistance to inhibiting effect of dexamethasone in patients with endogenous depression. Acta Psychiatrica Scandinavica 1980; 61: 169–77
   PubMed Web of Science ®Google Scholar
• Ransohoff D. F., Feinstein A. R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. New England Journal of Medicine 1978; 299: 926–30
   PubMed Web of Science ®Google Scholar
• Raskind M., Peskind E., Rivard M., et al. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. American Journal of Psychiatry 1982; 139: 1468–71
   PubMed Web of Science ®Google Scholar
• Rothschild A. J., Schatzberg A. F., Rosenbaum A. H., et al. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. British Journal of Psychiatry 1982; 141: 471–4
   PubMed Web of Science ®Google Scholar
• Rush A. J., Giles D. E., Roffwarg H. P., et al. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. Biological Psychiatry 1982; 17: 327–41
   PubMed Web of Science ®Google Scholar
• Schatzberg A. A., Rothschild A. J., Stahl J. B., et al. The dexamethasone suppression test: identification of subtypes of depression. American Journal of Psychiatry 1983; 140: 88–91
   PubMed Web of Science ®Google Scholar
• Schlesser M. A., Winokur G., Sherman B. M. Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. Archives of General Psychiatry 1980; 37: 737–43
   PubMed Web of Science ®Google Scholar
• Shapiro M. R., Lehman A. F. The diagnosis of depression in different clinical settings: an analysis of the literature on the dexamethasone suppression test. Journal of Nervous and Mental Disease 1983; 171: 714–20
   PubMed Web of Science ®Google Scholar
• Shulman R., Diewold P. A two-dose dexamethasone suppression test in patients with psychiatric illness. Canadian Psychiatric Association Journal 1977; 22: 417–22
   PubMedGoogle Scholar
• Spar J. E., Gerner R. Does the dexamethasone suppression test distinguish dementia from depression?. American Journal of Psychiatry 1982; 139: 238–40
   PubMed Web of Science ®Google Scholar
• Spitzer R. L., Endicott J., Robins E. Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd ed. Biometrics Research New York State Psychiatric Institute, New York 1978
   Google Scholar
• Targum S. D., Byrnes S. M., Sullivan A. C. Subtypes of unipolar depression distinguished by the dexamethasone suppression test. Journal of Affective Disorders 1982a; 4: 21–7
   PubMed Web of Science ®Google Scholar
• Targum S. D., Sullivan A. C., Byrnes S. M. Neuroendocrine interrelationships in major depressive disorder. American Journal of Psychiatry 1982b; 139: 282–6
   PubMed Web of Science ®Google Scholar
• Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. New England Journal of Medicine 1966; 274: 1171–3
   PubMed Web of Science ®Google Scholar
• Winokur A., Amsterdam J., Caroff S., et al. Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. American Journal of Psychiatry 1982; 139: 39–44
   PubMed Web of Science ®Google Scholar
• Yerushalmy J. Statistical problems in assessing methods of medical diagnosis, with special reference to X-ray techniques. Public Health Reports 1947; 62: 1432–49
   PubMed Web of Science ®Google Scholar